MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, SBFMW had -$2,176,618 decrease in cash & cash equivalents over the period. -$2,077,229 in free cash flow.

Cash Flow Overview

Change in Cash
-$2,176,618
Free Cash flow
-$2,077,229
Unit: Dollar
Positive Cash Flow Breakdown
    • Prepaid expenses
    • Inventory
    • Depreciation and amortization
    • Others
Negative Cash Flow Breakdown
    • Net (loss)
    • Accounts receivable
    • Accounts payable & accrued expen...
    • Others

Cash Flow
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents at beginning of period
--9,686,529 -
Net (loss)
-1,243,869 -2,140,927 -883,820 -2,950,605
Disposal of tangible assets
-7 10,250 -
Stock issued for services
-0 0 0
Intangible assets impairment
-131,788 554,650 1,061,809
Depreciation and amortization
76,859 98,581 96,163 137,326
Accounts receivable
609,601 -41,293 649,850 -492,384
Inventory
-78,399 -772,796 1,286,164 1,123,909
Deposits
71,740 ---
Prepaid expenses
-154,726 -189,082 -36,168 -255,548
Reduction in right-of-use asset
---147,016 -
Right-of-use asset
--109,434 --94,402
Reduction in right-of-use asset
52,788 ---
Accounts payable & accrued expenses
-455,836 -565,040 1,224,786 -849,702
Lease liability
-54,001 -57,782 -129,741 -
Earn-out payable
-0 0 0
Income tax payable
175 -152,874 162,992 -10,118
Net cash flows (used in) operating activities
-2,072,100 -1,616,006 -727,800 -2,987,267
Purchase of intangible assets
99,389 40,998 26,103 594,714
Purchase of equipment
5,129 -1,039 8,040 167,490
Net cash flows (used in) investing activities
-104,518 -50,209 -118,295 -667,802
Proceeds from public offering net (common stock)
-0 0 1,828,596
Exercise of warrants
0 724,500 0 2,195,312
Purchase of treasury stock
-0 0 0
Lease liability
---75,536
Net cash flows provided by financing activities
0 724,500 75,536 3,948,372
Net increase (decrease) in cash and cash equivalents
-2,176,618 -941,715 -770,560 293,304
Effect of exchange rate changes on cash
--97,165 -
Cash and cash equivalents at end of period
--9,306,438 -
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Net increase(decrease) in cash and cash...-$2,176,618 Prepaid expenses-$154,726 Inventory-$78,399 Depreciation andamortization$76,859 Reduction in right-of-useasset$52,788 Income tax payable$175 Net cash flows (usedin) operating...-$2,072,100 Net cash flows (usedin) investing...-$104,518 Canceled cashflow$362,947 Net (loss)-$1,243,869 Accounts receivable$609,601 Accounts payable &accrued expenses-$455,836 Purchase of intangibleassets$99,389 Purchase of equipment$5,129 Deposits$71,740 Lease liability-$54,001

Sunshine Biopharma Inc. (SBFMW)

Sunshine Biopharma Inc. (SBFMW)